Search

everythinglearnresearchcommunity

for

Search:↓

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

Vitamin D3 and its receptor are important for hair growth, and understanding receptors could help treat hair graying and skin cancer.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Danthron from Rhubarb causes melanoma cells to stop growing and die.

The document lists dermatology topics across life stages and notes hair loss can affect self-esteem and early skin cancer treatment is crucial.

Children with diabetes often have skin problems, which can be better managed with good blood sugar control.

Some patients lost hair after taking interferon alpha 2B, but it improved for some while still on the treatment and for others after stopping it.

Peanut agglutinin staining helps differentiate malignant melanoma from nevocellular nevus.

COCs can improve acne but may cause skin issues like cholasma; high estrogen is advised for hair loss concerns.

Xerosis and wrinkling are common in elderly skin, but some conditions can be harmful.

Finasteride and dutasteride increase sexual dysfunction reports.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Intravital imaging helps us better understand stem cells in their natural environment and could improve knowledge of organ regeneration and cancer development.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Psoriasis is the most common cause of erythroderma, and proper medical follow-up is crucial.

Hypertrichosis lanuginosa causes excessive fine hair growth, often linked to genetics or cancer, with limited treatment options.

Electric Follicle Stimulation may promote hair growth and density with no known side effects.

Correct skin biopsy techniques are crucial to avoid misdiagnosis of skin diseases.

Inactive hair follicle stem cells help prevent skin cancer.

Epidermal stem cells could lead to new treatments for skin and hair disorders.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.